Comparing Devices That Measure Body Fat and Lean Mass in Adults
Compares body composition measurements from different devices in healthy adults, including people with overweight.
Key facts
- Who runs it
- Foundation for the National Institutes of Health
- Where
- Boston, Menlo Park, and Phoenix, United StatesSee the 3 sites
- Trial code
- Registry title
- Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 29 Jun 2026
- Expected to end
- 30 Mar 2027
- Type of study
- Observational
- Record updated
- 26 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for 300 healthy adults to compare body measurements taken with different devices, scans and blood tests.
- Age
- 18 years or older
- Sex
- Women and men can join.
- Biomarker or test result
- BMI between 18.5 and 45 kg/m2. Weight stable (no more than 5 kg (11 lb) change) for 3 months before screening.
Main reasons for not taking part
- Pregnant or trying to become pregnant
- Medical or cosmetic implants, such as a pacemaker, metal joint replacement or breast implants
- Height over 77 inches or body weight over 400 lbs (181 kg)
- Claustrophobia, known HIV infection or known lipodystrophy
- Severe illness, such as end-stage kidney, liver or lung disease, NYHA III-IV heart failure or active malignancy
This trial only enrols healthy participants. The registry sentence this rests on: The study plans to enroll 300 healthy (having no life-threatening conditions or diseases; male and female) participants, 18 years of age or older.
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Being willing to provide written informed consent prior to participation Being willing to complete the study visits and comply with the study procedures
- Being willing to travel to the various study locations for On-site, DXA, MRI, and Phlebotomy visits
- Being willing to change into appropriate form-fitting clothing for 3DO assessments and/or appropriate gowns for DXA and MRI imaging
- Must have a BMI within the range of 18.5 - 45 kg/m2
- Being willing to refrain from all food, drink, and substances for 8 hours prior to the On-site visit(s) and phlebotomy visit
- Being willing to refrain from all food, drink, and substances for 4 hours prior to the DXA and MRI scan visits
- Being willing to refrain from any exercise or vigorous physical activity for 24 hours prior to all visits
- Stable weight (no more than 5 kg change) for 3 months prior to screening
- If recruited in the Phoenix, AZ area, participants must be willing to drive yourself to the Phoenix Office location for the On-site Visits 1 and 2 (if applicable) located at the Exponent Phoenix Office
Who cannot take part
- Having medical implants, such as a pacemaker or metal joint replacements, or other metal implants contraindicated for MRI
- Cosmetic implants, such as breast implants
- Prior amputation or major body-altering surgery that could invalidate body composition estimates
- Having claustrophobia or a history of claustrophobia
- Known HIV infection
- Known hydration abnormality (e.g., significant edema, end-stage renal disease, end-stage liver disease)
- Severe illness or life-threatening conditions such as end-stage kidney, liver, lung disease, NYHA III-IV heart failure, or active malignancy
- Being pregnant or attempting to become pregnant
- Having a height greater than DXA scanning limit (77 inches)
- Having a body weight greater than indicated for the equipment (400 lbs)
- Known Lipodystrophy
Where in United States
- Exponent BostonBoston, United StatesContact: Ariel DowlingTaking people
- Exponent Menlo ParkMenlo Park, United StatesContact: Erica Lively Site Lead, PhDTaking people
- Exponent PhoenixPhoenix, United StatesContact: Marysol LunaTaking people
About the trial
What the trial wants to find out
The purpose of this study is to evaluate body composition across a variety of medical, professional, and commercial devices, including: bioelectrical impedance analysis (BIA) devices, 3-dimensional optical imaging (3DO), manual anthropometry measurements, dual-energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI), and blood tests. The secondary study purpose is to compare body composition measurements from BIA devices, 3DO, and manual anthropometry measurements within a 1-week period for a subset of the study population.
Read full original descriptionShow less
The study plans to enroll 300 healthy (having no life-threatening conditions or diseases; male and female) participants, 18 years of age or older.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity (REAL-BODY)
- Plain-language title
- Comparing Devices That Measure Body Fat and Lean Mass in AdultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 26 October 2026